Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Garenoxacin (BMS284756) is a novel oral des-fluoro(6) quinolone for the treatment of Gram-positive and Gram-negative bacterial infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 4-5 weeks | $ 275.00 | |
10 mg | 4-5 weeks | $ 413.00 | |
25 mg | 4-5 weeks | $ 880.00 |
Description | Garenoxacin (BMS284756) is a novel oral des-fluoro(6) quinolone for the treatment of Gram-positive and Gram-negative bacterial infections. |
In vivo | The mean maximum plasma concentration (Cmax ) was 3.00 ± 1.12 μg/mL, time to maximum plasma concentration (Tmax ) was 3.0 ± 2.0 hours, and area under the curve for 24 hours (AUC0-24 ) was 40.7 ± 16.7 μg·h/mL. The half-life (T1/2 ) of GRNX could not be calculated because plasma concentrations remained high 24 hours after administration. Cmax was strongly associated with the GRNX dose per kilogram body weight (r = 0.85, P = 0.03).Clinically, fever resolved within 3 days of GRNX administration and C-reactive protein levels returned to normal 14 days after administration. One patient experienced temporary increases in serum transaminase levels[1]. |
Animal Research | Six male patients with infections who were undergoing MH received 200 mg GRNX once daily. Blood samples were taken before and at 1, 2, 4, 6, 12, and 24 hours after GRNX administration. Plasma GRNX concentrations were measured using high-performance liquid chromatography[1]. |
Synonyms | BMS284756 |
Molecular Weight | 426.41 |
Formula | C23H20F2N2O4 |
CAS No. | 194804-75-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2 mg/mL (4.69 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Garenoxacin 194804-75-6 Microbiology/Virology Antibacterial S. pneumonia Swiss mice Inhibitor Antibiotic BMS 284756 BMS-284756 BMS284756 DNA/RNA Synthesis Topoisomerase S. aureus gyrase mycoplasmas topoisomerase IV ureaplasmas inhibit Bacterial inhibitor